MedSci Healthcare Holdings Limited (HKG:2415)
Hong Kong
· Delayed Price · Currency is HKD 1.120
-0.020 (-1.75%)
Last updated: Mar 9, 2026, 3:52 PM HKT
HKG:2415 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 275.2 | 260.62 | 349.19 | 348.95 | 297.73 | 215.85 |
| Revenue Growth (YoY) | -10.78% | -25.36% | 0.07% | 17.20% | 37.93% | - |
| Cost of Revenue | 103.49 | 98.45 | 132.59 | 142.63 | 107.92 | 98.82 |
| Gross Profit | 171.72 | 162.17 | 216.61 | 206.32 | 189.81 | 117.03 |
| Selling, General & Admin | 122.72 | 140 | 146.9 | 168.29 | 122.84 | 68.91 |
| Research & Development | 30.91 | 23.24 | 39.86 | 35.01 | 24.41 | 18.08 |
| Operating Expenses | 175.04 | 177.26 | 200.35 | 205.85 | 153.67 | 87.49 |
| Operating Income | -3.32 | -15.09 | 16.26 | 0.48 | 36.14 | 29.54 |
| Interest Expense | -0.16 | -0.15 | -0.28 | -0.36 | -0.27 | -0.42 |
| Interest & Investment Income | 16.2 | 16.2 | 15.37 | 10.38 | 4.85 | 1.47 |
| Other Non Operating Income (Expenses) | 4.13 | 1.13 | 9.34 | 2.56 | -188.61 | 1.59 |
| EBT Excluding Unusual Items | 16.85 | 2.09 | 40.69 | 13.06 | -147.89 | 32.18 |
| Gain (Loss) on Sale of Investments | 23.41 | 23.41 | 6.97 | - | - | 1 |
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.84 | - |
| Other Unusual Items | - | - | 12.79 | -109.35 | - | - |
| Pretax Income | 40.26 | 25.5 | 60.45 | -96.29 | -147.06 | 33.17 |
| Income Tax Expense | 2.3 | 0.53 | 5.41 | 3.59 | 3.97 | 4.26 |
| Net Income | 37.96 | 24.97 | 55.04 | -99.88 | -151.03 | 28.91 |
| Net Income to Common | 37.96 | 24.97 | 55.04 | -99.88 | -151.03 | 28.91 |
| Net Income Growth | -12.48% | -54.64% | - | - | - | - |
| Shares Outstanding (Basic) | 541 | 541 | 518 | 473 | 9 | 10 |
| Shares Outstanding (Diluted) | 541 | 541 | 519 | 473 | 9 | 10 |
| Shares Change (YoY) | 0.20% | 4.23% | 9.74% | 5419.00% | -10.35% | - |
| EPS (Basic) | 0.07 | 0.05 | 0.11 | -0.21 | -17.64 | 3.03 |
| EPS (Diluted) | 0.07 | 0.05 | 0.08 | -0.21 | -17.64 | 3.03 |
| EPS Growth | -12.66% | -43.31% | - | - | - | - |
| Free Cash Flow | 69.55 | 54.61 | 37.86 | -14.56 | 36.46 | 55.09 |
| Free Cash Flow Per Share | 0.13 | 0.10 | 0.07 | -0.03 | 4.26 | 5.77 |
| Gross Margin | 62.40% | 62.23% | 62.03% | 59.13% | 63.75% | 54.22% |
| Operating Margin | -1.21% | -5.79% | 4.66% | 0.14% | 12.14% | 13.69% |
| Profit Margin | 13.79% | 9.58% | 15.76% | -28.62% | -50.73% | 13.40% |
| Free Cash Flow Margin | 25.27% | 20.95% | 10.84% | -4.17% | 12.25% | 25.52% |
| EBITDA | -2.3 | -14.16 | 17.4 | 1.62 | 37.12 | 30.31 |
| EBITDA Margin | -0.83% | -5.44% | 4.98% | 0.46% | 12.47% | 14.04% |
| D&A For EBITDA | 1.03 | 0.92 | 1.14 | 1.15 | 0.98 | 0.77 |
| EBIT | -3.32 | -15.09 | 16.26 | 0.48 | 36.14 | 29.54 |
| EBIT Margin | -1.21% | -5.79% | 4.66% | 0.14% | 12.14% | 13.69% |
| Effective Tax Rate | 5.71% | 2.08% | 8.95% | - | - | 12.84% |
Source: S&P Capital IQ. Standard template. Financial Sources.